Gräfelfing, Germany

Klaus Seibel

USPTO Granted Patents = 13 

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 131(Granted Patents)


Location History:

  • Grafelfing, DE (1986 - 1992)
  • Gräfelfing, DE (2002 - 2008)

Company Filing History:


Years Active: 1986-2008

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Inventor Klaus Seibel: A Pioneer in Cytostatic and Immunosuppressive Solutions

Introduction

Klaus Seibel, an accomplished inventor based in Gräfelfing, Germany, has significantly contributed to the fields of medicine and pharmaceuticals with his innovative work. With a portfolio of 13 patents, he has focused primarily on the development of advanced compounds aimed at treating various diseases, including tumors and autoimmune disorders.

Latest Patents

Klaus Seibel’s latest inventions revolve around novel aryl-substituted pyridylalkane, alkene, and alkine carboxamides. These compounds serve as cytostatic and immunosuppressive agents, providing new avenues for the treatment and prevention of tumors, alongside the management of immune reactions related to autoimmune diseases. Specifically, his patents outline the synthesis methods for these compounds, their use in medicaments, and their therapeutic applications. Another notable patent focuses on pyridyl alkane acid amides, emphasizing their role as cytostatics and immunosuppressives, showcasing his relentless pursuit of innovative healthcare solutions.

Career Highlights

Throughout his career, Klaus has worked with reputable companies such as Klinge Pharma GmbH and Astellas Deutschland GmbH. His experience in these organizations has played a vital role in refining his innovative ideas into practical applications, significantly benefiting the medical community.

Collaborations

Klaus Seibel has collaborated with talented peers, including Friedemann Reiter and Elfi Biedermann, further enhancing the quality and reach of his inventions. Their teamwork has enabled the exploration of new therapeutic possibilities and has resulted in the successful development of innovative medical solutions.

Conclusion

In summary, Klaus Seibel stands out as an influential inventor in the pharmaceutical industry, with a focus on creating effective treatments for serious health conditions. His latest patents reflect a deep understanding of medicinal chemistry and a commitment to advancing healthcare through innovation. The impact of his work continues to resonate in the fields of cytostatics and immunosuppressive therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…